Replies to post #243680 on Avid Bioservices Inc (CDMO)

[golfho]

I agree with your conclusion...

All along SK has been saying enrollment is on track, therefore assuming SK hasn't been BS'ing us on the enrollment, the movement of the expected 2nd look-in from expected end of 2015 (back in October of 2014) to mid 2016 (stated in this years ASM) should mean the trial is going much better than expected.

That's why my current favorite pick for final MOS is 15 months for Bavituximab combo vs. 10 months for Placebo combo.

Time will tell.

Regards
golfho

[Protector]

nuke661, I find that a very strong peace of research you have done here.

Thanks.

[asmarterwookie]

nuke661, thanks for the research....the problem...SK was probably making predictions based on assumptions.

wook